Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: A retrospective study in a single clinic

Clinical Nephrology

Volumn 56, Issue 2, 2001, Pages 89-95

  Stiles, K P ^a   Abbott, K C ^a   Welch, P G ^a   Yuan, C M ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Corticosteroids; FSGS; HMG CoA reductase inhibitors; Nephrotic syndrome

Indexed keywords

CHOLESTEROL; CORTICOSTEROID; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; ETHNOLOGY; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GENDER; HUMAN; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MEAN ARTERIAL PRESSURE; MEDICAL ASSESSMENT; NEGRO; NEPHROSIS; PROTEINURIA; REMISSION; RETROSPECTIVE STUDY; STEROID THERAPY; TIME;

ADRENAL CORTEX HORMONES; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; NEPHROTIC SYNDROME; PROTEINURIA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034900716     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Idiopathic adult focal-segmental glomuerulosclerosis: A clinicopathological study and response to steroid
2. The impact of prolonged immuno-suppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative restrospective study
3. Focal glomerulosclerosis: Natural history and treatment
4. The combination of lovastatin and enalapril in a model of progressive renal disease
5. The long-term prognosis of patients with focal-segmental glomerulosclerosis
6. Focal sclerosing glomerulopathy: Risk factors of progression and optimal mode of treatment
7. Focal segmental glomerulosclerosis in African Americans: Effects of steroids and ACE inhibitors
8. Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation
9. Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976 - 1979 and 1995 - 1997
10. Efficacy and variability of the antiproteinuric effect of Ace inhibition by lisinopril
11. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis
12. The prognosis of focal-segmental glomerular sclerosis of adulthood
13. Primary focal-segmental glomerulosclerosis: Clinical course and response to therapy
14. The racial prevalence of glomerular lesions in nephrotic adults
15. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy
16. The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy
17. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
18. Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy
19. Hyperlipidemia and its management in renal disease
20. Simvastatin in nephrotic syndrome
21. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis
22. Can prolonged treatment improve the prognosis in adults with focal-segmental glomerulosclerosis?
23. Focal-segmental glomerular sclerosis in adults: Presentation, course, and response to treatment
24. Incidence and long-term cost of steroid-related side effects after renal transplantation